Alkem enters into licensing agreement with BioTherapeutics
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Aims to achieve CDMO sales of US$ 400 million by 2028
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
USFDA completes PAI of Lupin’s biotech facility in Pune
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Subscribe To Our Newsletter & Stay Updated